However, recent observational studies have shown that patients with normal ALT may also develop NASH and progressive fibrosis, while patients with elevated ALT may have neither NASH nor progressive fibrosis [42–44]. Here, GPT is linked to metabolic dysfunction-associated steatohepatitis.